Total tumor resection, preoperative KPS score ≥60, IDH1/2 gene mutation, postoperative radiotherapy and chemotherapy were associated with better survival of patients with gliomas, while TERT promoter mutation was associated with poor survival (P<0.05). This evidence concerns the gene IDH1 and glioma.